TRIALS is a dynamic team of researchers aiming to identify new treatments for a range of disorders. Innovation and cross-collaboration are the cornerstones of our research program.
Associate Professor Olivia Dean
Director, IMPACT Trials
About our work
IMPACT TRIALS works with collaborators both nationally and internationally. There have been a number of completed trials with agents including; N-acetyl cysteine, minocycline, mitochondrial enhancers, asprin, and rosuvastatin. Data from these trials provides rich sources to explore not only primary efficacy but also underlying factors related to treatment response.
TRIALS ultimately aims both to provide interventions that can be rolled out into clinical practice and to identify factors that will enhance personalised medicine in psychiatry
See below our upcoming, current and past studies at IMPACT TRIALS